Skip to main content

November 2025

Dr. Reddy’s Biologics Hiring for Team Member / Team Lead R&D Roles

Experience in biological sciences, Product development- contribute to biological characterization and method development. Dr. Reddys Biologics. BTech or Masters in Biotechnology / Microbiology / Biochemistry
Interview for M.Pharm, B.Pharm, MSc in Production, Packing, QA at Annora Pharma
Granulation, Compression, FBP, Coating, Capsule Filling, Inspection
Formulation Development Openings at Bioplus Life Sciences - M.Pharm, PhD Apply
M.Pharm / Ph.D in Pharmaceutics studied in Top Colleges. Preferably CBSE / ICSE Board students with good academic records
Interview for Freshers B.Pharm in Production Department at Kusum Healthcare
WALK-IN INTERVIEW FOR FRESHERS/EXPERIENCED CANDIDATES FOR Production Department. Kusum Healthcare
Openings in Regulatory Affairs, QC at Mepro pharmaceuticals
Forecast inventory and schedule production. Raise material orders and coordinate deliveries, Liaise with departments for protect execution. Prepare cost sheets and stock statements.
USD 700 Million funding to Merck fuels next-generation cancer drug development
Through a new research and development funding agreement, the company will receive $700 million from Blackstone Life Sciences to support late-stage clinical development of sac-TMT.
Novo Nordisk delivers strong 9-month growth as Obesity & Rare-Disease pipeline advances
In a compelling report released today, Novo Nordisk A/S (Bagsværd, Denmark) announced robust performance for the first nine months of 2025 along with noteworthy pipeline developments that reflect the company’s ambition to redefine the treatment of chronic and rare diseases.
Scientists Engineer First-Ever Recombinant Snake Antivenom
In a historic leap for global health, an international team of scientists has developed the world’s first genetically engineered, product-ready snake antivenom — a potential game-changer for treating bites from some of Africa’s most lethal snakes, including cobras, mambas, and rinkhals.
FDA Introduces New Guidance to Streamline Biosimilar Development and Cut Drug Costs
The U.S. Food and Drug Administration (FDA) has announced new measures aimed at accelerating the development of biosimilar medicines and lowering the overall cost of biologic treatments in the United States.
Cipla to acquire Inzpera Healthsciences, strengthens focus on Paediatric and Wellness Segment
Pharmaceutical major Cipla Limited has announced the signing of definitive agreements to acquire 100% equity stake in Inzpera Healthsciences Limited, a company engaged in developing and marketing differentiated paediatric and wellness products. The announcement was made through a corporate filing with the Bombay Stock Exchange